BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/03/2024

FDA Releases Revised Draft Guidance for Early Alzheimer's Disease Treatment

The FDA has made available a revised draft guidance to help pharmaceutical companies develop drugs for treating early stages of sporadic Alzheimer's disease, stages that occur before overt dementia sets in.

Source: Federal Register — Food and Drug AdministrationOpen original release →